Structural determinants of cytochrome P450 substrate specificity, binding affinity and catalytic rate

Chemico-Biological Interactions

Volumn 115, Issue 3, 1998, Pages 175-199

  Lewis, D F V ^a   Eddershaw, P J ^b   Dickins, M ^b   Tarbit, M H ^b   Goldfarb, P S ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450;

BINDING AFFINITY; CHEMICAL STRUCTURE; CRYSTAL STRUCTURE; ELECTRONICS; ENZYME MECHANISM; ENZYME METABOLISM; ENZYME SPECIFICITY; ENZYME SUBSTRATE; HYDROGEN BOND; HYDROPHOBICITY; NONHUMAN; REVIEW; SOLVATION;

EID: 18744429213     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(98)00068-4     Document Type: Article

References (66)

1. Porter T.D., Coon M.J. Cytochrome P450: multiplicity of isoforms, substrates and catalytic and regulatory mechanisms. J. Biol. Chem. 266:1991;13469-13472.
2. Nelson D.R., Koymans L., Kamataki T. et al. P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics. 6:1996;1-42.
3. Lewis D.F.V., Moereels H., Lake B.G., Ioannides C., Parke D.V. Molecular modelling of enzymes and receptors involved in carcinogenesis: QSARs and COMPACT-3D. Drug Metab. Rev. 26:1994;261-285.
4. Lewis D.F.V. Quantitative structure-activity relationships in substrates, inducers and inhibitors of cytochrome P4501 (CYP1). Drug Metab. Rev. 29:1997;589-650.
5. Lewis D.F.V., Lake B.G. Molecular modelling of CYP1A subfamily members based on an alignment with CYP102: rationalization of CYP1A substrate specificity in terms of active site amino acid residues. Xenobiotica. 26:1996;723-753.
6. Lewis D.F.V., Bird M.G., Parke D.V. Molecular modelling of CYP2E1 enzymes from rat, mouse and man: a possible explanation for the species differences in butadiene metabolism and rationalization of CYP2E substrate specificity. Toxicology. 118:1997;93-113.
7. Koymans L.M.H., Vermeulen N.P.E., van Acker S.A.B.E. et al. A predictive model for substrates of cytochrome P-450-debrisoquine (2D6). Chem. Res. Toxicol. 5:1992;211-219.
8. Lewis D.F.V., Lake B.G., Parke D.V. Molecular orbital-generated QSARs in an homologous series of alkoxy resorufins and studies of their interactive docking with cytochromes P450. Xenobiotica. 25:1995;1355-1369.
9. Lewis D.F.V., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular modelling of CYP3A4 from an alignment with CYP102: identification of key interactions between putative active site residues and CYP3A-specific chemicals. Xenobiotica. 26:1996;1067-1086.
10. Lewis D.F.V., Eddershaw P.J., Goldfarb P.S., Tarbit M.H. Molecular modelling of cytochrome P4502D6 (CYP2D6) based on an alignment with CYP102: strcutral studies on specific CYP2D6 substrate metabolism. Xenobiotica. 27:1997;319-340.
11. Ponnuswamy P.K. Hydrophobic characteristics of folded proteins. Prog. Biophys. Mol. Biol. 59:1993;57-103.
12. P.W. Atkins, Physical Chemistry, 3rd ed., Oxford University Press, Oxford, 1987, p.272.
13. cam. J. Mol. Biol. 195:1987;687-700.
14. BM-3, a prototype for microsomal P450s. Science. 261:1993;731-736.
15. terp and 2.3Å resolution. J. Mol. Biol. 236:1994;1169-1185.
16. eryF involved in erythromycin biosynthesis. Struct. Biol. 2:1995;144-153.
17. Mackman R., Tschirret-Guth R.A., Smith G. et al. Active site topologies of human CYP2D6 and its aspartate-301→glutamate, asparagine and glycine mutants. Arch. Biochem. Biophys. 331:1996;134-140.
18. Williams D.H., Cox J.P.L., Doig A.J. et al. Towards a semi-quantitative estimation of binding constants. J. Am. Chem. Soc. 113:1991;7020-7030.
19. Griffin B.W., Peterson J.A. Camphor binding by Pseudomonas putida cytochrome P-450: kinetics and thermodynamics of the reaction. Biochemistry. 11:1972;4740-4746.
20. Perekyla M., Pakkanen T.A. Quantum mechanical model assembly calculations of energetics of binding of ligands to protein receptors. Biochem. Soc. Trans. 24:1996;1435.
21. cam substrate analogues designed to fill extra space in the substrate binding pocket. Biochemistry. 35:1996;1485-1499.
22. Lewis D.F.V. The calculation of molar polarizability by the CNDO/2 method: correlation with the hydrophobic parameter, log P. J. Comp. Chem. 10:1989;145-151.
23. Z. Simon, I. Motoc, A. Chiriac, Molecular basis of receptor-ligand interactions, in: N. Voiculetz, I. Motoc, Z. Simon (Eds.), Specific Interactions and Biological Recognition Processes, CRC Press, Boca Raton, FL, 1993, pp.17-79.
24. V. Pliska, B. Testa, H. van de Waterbeemd (Eds.), Lipophilicity in Drug Action and Toxicology, VCH, Weinheim, 1996.
25. Smith D.A. Species differences in metabolism and pharmacokinetics: are we close to an understanding? J. Phys. Chem. Ref. Data. 18:1989;1111-1229.
26. Sharp K.A., Nicholls A., Fine R.F., Honig B. Reconciling the magnitude of the microscopic and macroscopic hydrophobic effects. Science. 255:1991;106-109.
27. Poulos T.L., Finzel B.C., Howard A.J. Crystal structure of substrate-free Psendomonas putida cytochrome P-450. Biochemistry. 25:1986;5314-5322.
28. Jefcoate C.R.E., Graylor J.L., Calabrese R.L. Ligand interactions with cytochrome P-450 I: binding of primary amines. Biochemistry. 8:1969;3455-3463.
29. Sangster J. Octanol-water partition coefficients of simple organic compounds. J. Phys. Chem. Ref. Data. 18:1989;1111-1229.
30. cam. Biochemistry. 34:1995;8982-8988.
31. Ruckpaul K., Rein H., Blanck J. Regulation mechanisms of the activity of the hepatic endoplasmic cytochrome P-450. Front. Biotransform. 1:1989;1-65.
32. Blanck J., Rein H., Sommer M., Ristau O., Smettan G., Ruckpaul K. Correlations between spin equilibrium shift, reduction rate and N-demethylation activity in liver microsomal cytochrome P-450 and a series of benzphetamine analogues as substrates. Biochem. Pharmacol. 32:1983;1683-1688.
33. Lewis D.F.V., Ioannides C., Parke D.V. A quantitative structure-activity relationship study on a series of ten para-substituted toluenes binding to cytochrome P4502B4 (CYP2B4) and also their hydroxylation rates. Biochem. Pharm. 50:1995;619-625.
34. White R.E., McCarthy M.B. Active site mechanics of liver microsomal cytochrome P450. Arch. Biochem. Biophys. 246:1986;19-32.
35. D.F.V. Lewis, B.G. Lake, Molecular modelling of human CYP2B isoforms and their interaction with substrates, inhibitors and redox components, Xenobiotica 27(1997) (in press).
36. Negishi M., Iwasaki M., Juvonen R.O., Sueyoshi T., Darden T.A., Pedersen L.G. Structural flexibility and functional versatility of cytochrome P450 and rapid evolution. Mutat. Res. 350:1996;43-50.
37. coh by the mutation of a single amino acid residue. Nature. 339:1989;632-634.
38. Juvonen R.O., Iwasaki M., Negishi M. Structural function of residue-209 in coumarin 7-hydroxylase. J. Biol. Chem. 266:1991;16431-16435.
39. Lewis D.F.V., Lake B.G. Molecular modelling of members of the P4502A sub-family: application to studies of enzyme specificity. Xenobiotica. 25:1995;585-598.
40. D.F.V. Lewis, J.M. Pratt, The P450 catalytic cycle and oxygenation mechanisms, Drug Metab. Rev. 30 (1998) 739-86.
41. Yin H., Anders H., Korzekwa K.R. et al. Designing safer chemicals: predicting the rates of metabolism of halogenated alkanes. Proc. Natl. Acad. Sci. USA. 92:1995;11076-11080.
42. Traylor T.G., Xu F. Model reactions related to cytochrome P-450. Effects of alkene structure on the rates of epoxide formation. J. Am. Chem. Soc. 110:1988;1953-1958.
43. Galliani G., Nali M., Rindone B., Tollari S., Rocchetti M., Salmona M. The rate of N-demethylation of N,N-dimethylanilines and N-methylanilines by rat-liver microsomes is related to their first ionization potential, their lipophilicity and to a steric bulk factor. Xenobiotica. 16:1986;511-517.
44. Constantino L., Rosa E., Iley J. The microsomal demethylation of N,N-dimethylbenzamides. Biochem. Pharmacol. 44:1992;651-658.
45. Cnubben N.H.P., Vervoort J., Veeger C., Rietjens I.M.C.M. Study on the regioselectivity and mechanism of the aromatic hydroxylation of monofluoroanilines. Chem. Biol. Interact. 85:1992;151-172.
46. Zbaida S., Levine W.G. Role of electronic factors in binding and reduction of azo dyes by hepatic microsomes. J. Pharmacol. Exp. Ther. 260:1992;554-561.
47. Tyrakowska B., Cnubben N.H.P., Soffers A.E.M.F., Wobbes T., Rietjens I.M.C.M. Comparative MO-QSAR studies in various species including man. Chem. Biol. Interact. 100:1996;187-201.
48. Lewis D.F.V. Cytochromes P450: Structure, Function and Mechanism. 1996;Taylor & Francis, London.
49. D.F.V. Lewis, C. Ioannides, D.V. Parke, An improved version of the COMPACT procedure for the evaluation of P450-mediated chemical activation, Drug Metab. Rev. 30 (1998) 709-737.
50. Hansch C., Leo A. Substituent Constants for Correlation Analysis in Chemistry and Biology. 1979;WileyWiley, New York.
51. Chothia C. Structural invariants in protein folding. Nature. 254:1975;304-308.
52. Miller S., Janin J., Lesk A.M., Chothia C. Interior and surface of monomeric proteins. J. Mol. Biol. 196:1987;641-656.
53. T.E. Creighton, Proteins: Structures and Molecular Properties, 2nd ed., Freeman, New York, 1993.
54. Roseman M.A. Hydrophilicity of polar amino acid side-chains is markedly reduced by flanking peptide bonds. J. Mol. Biol. 200:1988;513-522.
55. cam mono-oxygenase: a possible role of the hydroxy amino acid in oxygen activation. Proc. Natl. Acad. Sci. USA. 86:1989;7823-7827.
56. Radzicka A., Wolfenden R. Comparing the polarities of the amino acids: side-chain distribution coefficients between the vapor phase, cyclohexane, 1-octanol, and neutral aqueous solution. Biochemistry. 27:1988;1664-1670.
57. Kollman P.A., Merz K.M. Computer modelling of the interactions of complex molecules. Accounts Chem. Res. 23:1990;246-252.
58. Morris G.M., Goodsell D.S., Huey R., Olson A.J. Distributed automated docking of flexible ligands to proteins: parallel applications of AutoDock 2.4. J. Comput. Aided Mol. Des. 10:1996;293-304.
59. Walshaw J., Goodfellow J.M. Distribution of solvent molecules around apolar side-chains in protein crystals. J. Mol. Biol. 231:1993;392-414.
60. Hollebone B.R., Brownlee L.J. A thermodynamic QSAR analysis of the polysubstrate monooxygenase responses to xenobiotic chemicals. Toxicol. Lett. 79:1995;157-168.
61. Hansch C., Björkroth J.P., Leo A. Hydrophobicity and central nervous system agents: on the principle of minimal hydrophobicity in drug design. J. Pharm. Sci. 76:1987;663-687.
62. Wolfenden R., Andersson L., Cullis P.M., Southgate C.C.B. Affinities of amino acid side-chains for solvent water. Biochemistry. 20:1981;849-855.
63. Bash P.A., Singh U.C., Langridge R., Kollman P.A. Free energy calculations by computer simulation. Science. 236:1987;564-568.
64. Cramer C.J., Truhlar D.G. An SCF solvation model for the hydrophobic effect and absolute free energies of aqueous solution. Science. 256:1992;213-216.
65. Grootenhuis P.D.J., Kollman P.A. Crown ether-neutral molecular interactions studies by molecular mechanics, normal mode analysis, and free energy perturbation calculations: near quantitative agreement between theory and experimental binding free energies. J. Am. Chem. Soc. 111:1989;4046-4051.
66. M. Delaage, Physicochemical aspects of molecular recognition, in: M. Delaage (Ed.), Molecular Recognition Mechanisms, VCH, New York, 1991, pp. 1-13.